Medical and surgical management of neovascular glaucoma
Timely recognition and comprehensive treatment - encompassing IOP control, ischemic drive reduction, and inflammation management - remain critical in the management of NVG. As research illuminates additional molecular targets and refines surgical interventions, the promise of a more personalized, biomarker-driven approach to NVG management continues to grow.
Authors
- Ahmad Santina (ORCID: https://orcid.org/0000-0002-9578-6362)
- Victoria L. Tseng (ORCID: https://orcid.org/0000-0003-4993-945X)
- Justin S. Yun (ORCID: https://orcid.org/0009-0009-1671-6875)
Institutions
- University of California, Los Angeles (US)
- Doheny Eye Institute (US)
Publication Details
- Journal
- Current Opinion in Ophthalmology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1097/icu.0000000000001151
- Citations
- 6
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 10.24